Cargando…
E‐cadherin expression is associated with somatostatin analogue response in acromegaly
Acromegaly is a rare disease resulting from hypersecretion of growth hormone (GH) and insulin‐like growth factor 1 (IGF1) typically caused by pituitary adenomas, which is associated with increased mortality and morbidity. Somatostatin analogues (SSAs) represent the primary medical therapy for acrome...
Autores principales: | Venegas‐Moreno, Eva, Flores‐Martinez, Alvaro, Dios, Elena, Vazquez‐Borrego, Mari C., Ibañez‐Costa, Alejandro, Madrazo‐Atutxa, Ainara, Japón, Miguel A., Castaño, Justo P., Luque, Raúl M., Cano, David A., Soto‐Moreno, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484433/ https://www.ncbi.nlm.nih.gov/pubmed/30843342 http://dx.doi.org/10.1111/jcmm.13851 |
Ejemplares similares
-
Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2017) -
MON-467 Expression of Somatostatin Receptors in Aggressive Non-Functioning Pituitary Adenomas
por: Soto, Alfonso, et al.
Publicado: (2019) -
Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features
por: Flores-Martinez, Álvaro, et al.
Publicado: (2020) -
Neurocognitive Function in Acromegaly after Surgical Resection of GH-Secreting Adenoma versus Naïve Acromegaly
por: Martín-Rodríguez, Juan Francisco, et al.
Publicado: (2013) -
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
por: Franck, S. E., et al.
Publicado: (2015)